Immunocore Holdings (IMCR) EBT (2023 - 2026)

Immunocore Holdings has disclosed EBT across 4 years of filings, most recently posting $13.3 million for Q1 2026.

• EBT for Q1 2026 came in at $13.3 million, up 118.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.9 million (up 47.69% YoY), and the FY2025 annual result was -$19.1 million, up 63.92% from the prior year.
• EBT came in at $13.3 million for Q1 2026 at Immunocore Holdings, up from -$15.8 million in the prior quarter.
• In the past five years, EBT ranged from a high of $13.3 million in Q1 2026 to a low of -$25.6 million in Q4 2023.
• The 4-year median for EBT is -$10.1 million (2024), against an average of -$9.2 million.
• Across the five-year window, EBT soared 733.52% in 2024 and plunged 95.01% in 2025, its largest moves.
• Immunocore Holdings' EBT stood at -$25.6 million in 2023, then rose by 3.2% to -$24.8 million in 2024, then surged by 36.37% to -$15.8 million in 2025, then jumped by 184.03% to $13.3 million in 2026.
• The last three EBT figures came in at $13.3 million (Q1 2026), -$15.8 million (Q4 2025), and $304000.0 (Q3 2025), per Business Quant data.